---
title: "Herpesvirus–autoantigen antibody networks linked to chronic disease in large biobank profiling"
id: "nature-immunology-2-large-scale-antibody-reactome-profiling-identifies-herpesvirus-autoantigen"
canonical_url: "https://medichelpline.com/clinical-feed/nature-immunology-2-large-scale-antibody-reactome-profiling-identifies-herpesvirus-autoantigen"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "Nature Immunology"
source_url: "https://www.nature.com/articles/s41590-026-02674-5"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Herpesvirus–autoantigen antibody networks linked to chronic disease in large biobank profiling
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-immunology-2-large-scale-antibody-reactome-profiling-identifies-herpesvirus-autoantigen
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** Nature Immunology
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41590-026-02674-5)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The study profiled immunoglobulin G reactivities to more than **4,600 herpesvirus peptides** and over **15,000 human proteins**, using multiplexed protein display, across two Mass General Brigham Biobank cohorts (discovery n = 1,289; replication n = 763). - Investigators reported 4,943 false-discovery-rate significant associations that replicated across cohorts; these associations involved 106 distinct autoantigens. - The cohort analysis identified previously uncharacterized viral–host immune axes, with PHLDA1 and ZNF550 named as specific autoantigens linked to viral reactivities. - Eleven autoantigens were predicted by viral seroreactivity with greater than 85% accuracy on independent validation, according to data reported. - Two of those predictive autoantigens showed viral–host sequence homology consistent with possible molecular mimicry; the authors described this as evidence supporting mechanistic plausibility, not proof of causation. - The authors integrated immune reactivities with longitudinal electronic health record follow-up to connect viral–autoantigen signals to incident diseases. - Cytomegalovirus formed the largest multimorbid disease network in their analysis; **Epstein–Barr virus** targeted pleiotropic autoimmune hubs; **herpes simplex viruses** produced partially overlapping networks. - The paper produces a herpesvirus–autoantigen–disease network atlas and prioritizes candidate viral–host immune axes for subsequent mechanistic investigation. - The source did not report experimental intervention details, therapeutic dosing, or causal validation experiments; mechanistic proof remains to be established in follow-up studies.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41590-026-02674-5#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Immunology](https://media.springernature.com/full/nature-cms/uploads/product/ni/header-ce329d5b570f961b651db20c364a103a.svg) ](https://www.nature.com/ni) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41590-026-02674-5) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/ni/research-articles) * [ Reviews & Analysis ](https://www.nature.com/ni/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/ni/news-and-comment) * [ Videos ](https://www.nature.com/ni/video) * [ Current issue ](https://www.nature.com/ni/current-issue) * [ Collections ](https://www.nature.com/ni/collections) * [Follow us on X ](https://twitter.com/NatImmunol) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/ni/aims) * [ Journal Information ](https://www.nature.com/ni/journal-information) * [ Editors ](https://www.nature.com/ni/editors) * [ Journal Metrics ](https://www.nature.com/ni/journal-impact) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/ni/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/ni/reviews-cross-journal-editorial-team) * [ Our publishing models ](https://www.nature.com/ni/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/ni/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/ni/editorial-policies) * [ Content Types ](https://www.nature.com/ni/content) * [ Web Feeds ](https://www.nature.com/ni/web-feeds) * [ Posters ](https://www.nature.com/ni/posters) * [ Contact ](https://www.nature.com/ni/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/ni/submission-guidelines) * [ For Reviewers ](https://www.nature.com/ni/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/ni/open-access-funding) * [Submit manuscript ](https://mts-ni.nature.com/cgi-bin/main.plex) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) 1. [nature](https://www.nature.com/) 2. [nature immunology](https://www.nature.com/ni) 3. [resources](https://www.nature.com/ni/articles?type=resource) 4. article Large-scale antibody reactome profiling identifies herpesvirus–autoantigen associations that underlie chronic diseases [ Download PDF ](https://www.nature.com/articles/s41590-026-02674-5.pdf) [ Download PDF ](https://www.nature.com/articles/s41590-026-02674-5.pdf) * Resource * [Open access](https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research) * Published: 20 November 2026 # Large-scale antibody reactome profiling identifies herpesvirus–autoantigen associations that underlie chronic diseases * [Sanghun Lee](https://www.nature.com/articles/s41590-026-02674-5#auth-Sanghun-Lee-Aff1-Aff2) [ORCID: orcid.org/0000-0002-0573-9555](https://orcid.org/0000-0002-0573-9555)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[2](https://www.nature.com/articles/s41590-026-02674-5#Aff2) [na1](https://www.nature.com/articles/s41590-026-02674-5#na1), * [Nicole Prince](https://www.nature.com/articles/s41590-026-02674-5#auth-Nicole-Prince-Aff1-Aff3) [ORCID: orcid.org/0000-0002-8506-1122](https://orcid.org/0000-0002-8506-1122)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3) [na1](https://www.nature.com/articles/s41590-026-02674-5#na1), * [Qingwen Chen](https://www.nature.com/articles/s41590-026-02674-5#auth-Qingwen-Chen-Aff1-Aff4) [ORCID: orcid.org/0000-0002-2946-4947](https://orcid.org/0000-0002-2946-4947)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[4](https://www.nature.com/articles/s41590-026-02674-5#Aff4), * [Xueying Chen](https://www.nature.com/articles/s41590-026-02674-5#auth-Xueying-Chen-Aff1) [ORCID: orcid.org/0009-0004-7852-4311](https://orcid.org/0009-0004-7852-4311)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1), * [Junwei Lu](https://www.nature.com/articles/s41590-026-02674-5#auth-Junwei-Lu-Aff5)[5](https://www.nature.com/articles/s41590-026-02674-5#Aff5), * [Kevin M. Mendez](https://www.nature.com/articles/s41590-026-02674-5#auth-Kevin_M_-Mendez-Aff1) [ORCID: orcid.org/0000-0002-8832-2607](https://orcid.org/0000-0002-8832-2607)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1), * [Rachel S. Kelly](https://www.nature.com/articles/s41590-026-02674-5#auth-Rachel_S_-Kelly-Aff1-Aff3) [ORCID: orcid.org/0000-0003-3023-1822](https://orcid.org/0000-0003-3023-1822)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3), * [Julian Hecker](https://www.nature.com/articles/s41590-026-02674-5#auth-Julian-Hecker-Aff1-Aff3) [ORCID: orcid.org/0000-0001-7918-089X](https://orcid.org/0000-0001-7918-089X)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3), * [Dmitry Prokopenko](https://www.nature.com/articles/s41590-026-02674-5#auth-Dmitry-Prokopenko-Aff6) [ORCID: orcid.org/0000-0002-1844-5652](https://orcid.org/0000-0002-1844-5652)[6](https://www.nature.com/articles/s41590-026-02674-5#Aff6), * [Michael J. McGeachie](https://www.nature.com/articles/s41590-026-02674-5#auth-Michael_J_-McGeachie-Aff1-Aff3) [ORCID: orcid.org/0000-0001-5566-2712](https://orcid.org/0000-0001-5566-2712)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3), * [Rinku Sharma](https://www.nature.com/articles/s41590-026-02674-5#auth-Rinku-Sharma-Aff1-Aff3) [ORCID: orcid.org/0000-0003-3036-2080](https://orcid.org/0000-0003-3036-2080)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3), * [Yulu Chen](https://www.nature.com/articles/s41590-026-02674-5#auth-Yulu-Chen-Aff1) [ORCID: orcid.org/0000-0003-2208-7242](https://orcid.org/0000-0003-2208-7242)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1), * [Andrea Aparicio](https://www.nature.com/articles/s41590-026-02674-5#auth-Andrea-Aparicio-Aff1)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1), * [Tao Guo](https://www.nature.com/articles/s41590-026-02674-5#auth-Tao-Guo-Aff1) [ORCID: orcid.org/0009-0005-8960-9203](https://orcid.org/0009-0005-8960-9203)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1), * [Ofer Levy](https://www.nature.com/articles/s41590-026-02674-5#auth-Ofer-Levy-Aff3-Aff7-Aff8) [ORCID: orcid.org/0000-0002-5859-1945](https://orcid.org/0000-0002-5859-1945)[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3),[7](https://www.nature.com/articles/s41590-026-02674-5#Aff7),[8](https://www.nature.com/articles/s41590-026-02674-5#Aff8), * [Nicholas J. W. Rattray](https://www.nature.com/articles/s41590-026-02674-5#auth-Nicholas_J__W_-Rattray-Aff9-Aff10) [ORCID: orcid.org/0000-0002-3528-6905](https://orcid.org/0000-0002-3528-6905)[9](https://www.nature.com/articles/s41590-026-02674-5#Aff9),[10](https://www.nature.com/articles/s41590-026-02674-5#Aff10), * [Zahra Rattray](https://www.nature.com/articles/s41590-026-02674-5#auth-Zahra-Rattray-Aff9-Aff10) [ORCID: orcid.org/0000-0002-8371-8549](https://orcid.org/0000-0002-8371-8549)[9](https://www.nature.com/articles/s41590-026-02674-5#Aff9),[10](https://www.nature.com/articles/s41590-026-02674-5#Aff10), * [Christoph Lange](https://www.nature.com/articles/s41590-026-02674-5#auth-Christoph-Lange-Aff1-Aff3-Aff5)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3),[5](https://www.nature.com/articles/s41590-026-02674-5#Aff5), * [H. Benjamin Larman](https://www.nature.com/articles/s41590-026-02674-5#auth-H__Benjamin-Larman-Aff11) [ORCID: orcid.org/0000-0001-7863-196X](https://orcid.org/0000-0001-7863-196X)[11](https://www.nature.com/articles/s41590-026-02674-5#Aff11) & * … * [Jessica A. Lasky-Su](https://www.nature.com/articles/s41590-026-02674-5#auth-Jessica_A_-Lasky_Su-Aff1-Aff3) [ORCID: orcid.org/0000-0001-6236-4705](https://orcid.org/0000-0001-6236-4705)[1](https://www.nature.com/articles/s41590-026-02674-5#Aff1),[3](https://www.nature.com/articles/s41590-026-02674-5#Aff3) Show authors [_Nature Immunology_](https://www.nature.com/ni) (2026) [Cite this article](https://www.nature.com/articles/s41590-026-02674-5#citeas) Save article [ View saved research ](https://www.nature.com/saved-research) ## Abstract Herpesviruses infect nearly all humans and have long been implicated in autoimmune and chronic diseases, yet their interactions with host proteins have not been systematically characterized. We profiled immunoglobulin G reactivities to >4,600 herpesvirus peptides and >15,000 human proteins using multiplexed protein display in two Mass General Brigham Biobank cohorts (discovery _n_ = 1,289; replication _n_ = 763), with longitudinal electronic health record follow-up. We identified and replicated 4,943 FDR-significant associations across 106 autoantigens, including previously uncharacterized viral–autoantigen axes, such as PHLDA1 and ZNF550. Eleven autoantigens were predicted by viral reactivities with >85% accuracy in independent validation, two of which exhibited viral–host sequence homology consistent with possible molecular mimicry. Integrating immune reactivities with incident diseases revealed virus-specific networks. Cytomegalovirus formed the largest multimorbid network, Epstein–Barr virus converged on pleiotropic autoimmune hubs and herpes simplex viruses formed partially overlapping networks. These findings define a herpesvirus–autoantigen–disease network atlas and prioritize candidate viral–host immune axes for mechanistic investigation. ### Explore related subjects Discover the latest articles and news in related subjects. * [Antibodies](https://www.nature.com/subjects/antibodies) * [Autoimmune diseases](https://www.nature.com/subjects/autoimmune-diseases) * [Viral infection](https://www.nature.com/subjects/viral-infection) * [Molecular Characterization of Herpesviruses and Host Interactions](https://www.nature.com/subjects/molecular-characterization-of-herpesviruses-and-host-interactions) ## Main Autoimmunity involves activation of an immune response against the body’s healthy cells and tissues[1](https://www.nature.com/articles/s41590-026-02674-5#ref-CR1 "Sundaresan, B., Shirafkan, F., Ripperger, K. & Rattay, K. The role of viral infections in the onset of autoimmune diseases. Viruses 15, 782 https://doi.org/10.3390/v15030782 \(2023\)."), which can damage organs and lead to chronic disease[2](https://www.nature.com/articles/s41590-026-02674-5#ref-CR2 "Cho, J. H. & Gregersen, P. K. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 365, 1612–1623 https://doi.org/10.1056/NEJMra1100030 \(2011\)."). Viral infections are recognized environmental triggers of autoimmunity[3](https://www.nature.com/articles/s41590-026-02674-5#ref-CR3 "von Herrath, M. G., Fujinami, R. S. & Whitton, J. L. Microorganisms and autoimmunity: making the barren field fertile? Nat. Rev. Microbiol. 1, 151–157 https://doi.org/10.1038/nrmicro754 \(2003\)."), potentially provoking aberrant immune responses through mechanisms such as molecular mimicry, bystander activation and epitope spreading. In some cases, this leads to the development of highly specific autoantibodies that target the host’s own cells and tissues and may ultimately lead to disease development[4](https://www.nature.com/articles/s41590-026-02674-5#ref-CR4 "Leslie, D., Lipsky, P. & Notkins, A. L. Autoantibodies as predictors of disease. J. Clin. Invest. 108, 1417–1422 https://doi.org/10.1172/JCI14452 \(2001\)."). These autoantibodies are increasingly recognized as useful biomarkers, particularly during the prodromal period, when cellular damage is occurring in the absence of overt clinical symptoms[5](https://www.nature.com/articles/s41590-026-02674-5#ref-CR5 "Dayan, C. M. & Daniels, G. H. Chronic autoimmune thyroiditis. N. Engl. J. Med. 335, 99–107 https://doi.org/10.1056/NEJM199607113350206 \(1996\)."),[6](https://www.nature.com/articles/s41590-026-02674-5#ref-CR6 "Leslie, R. D., Atkinson, M. A. & Notkins, A. L. Autoantigens IA-2 and GAD in type I \(insulin-dependent\) diabetes. Diabetologia 42, 3–14 https://doi.org/10.1007/s001250051105 \(1999\)."). Despite substantial progress linking viral exposures to autoantibody formation, these relationships have not been systematically characterized at cohort scale across large, deeply phenotyped populations. Herpesviruses represent some of the most well-documented viral species implicated in chronic disease, and they have been implicated across a range of conditions[1](https://www.nature.com/articles/s41590-026-02674-5#ref-CR1 "Sundaresan, B., Shirafkan, F., Ripperger, K. & Rattay, K. The role of viral infections in the onset of autoimmune diseases. Viruses 15, 782 https://doi.org/10.3390/v15030782 \(2023\)."),[7](https://www.nature.com/articles/s41590-026-02674-5#ref-CR7 "Serafini, B. et al. Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204, 2899–2912 https://doi.org/10.1084/jem.20071030 \(2007\)."),[8](https://www.nature.com/articles/s41590-026-02674-5#ref-CR8 "Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321–327 https://doi.org/10.1038/s41586-022-04432-7 \(2022\)."),[9](https://www.nature.com/articles/s41590-026-02674-5#ref-CR9 "Cusick, M. F., Libbey, J. E. & Fujinami, R. S. Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol 25, 496–501 https://doi.org/10.1097/BOR.0b013e328362004d \(2013\)."),[10](https://www.nature.com/articles/s41590-026-02674-5#ref-CR10 "Ascherio, A. & Munger, K. L. EBV and autoimmunity. Curr. Top. Microbiol. Immunol. https://doi.org/10.1007/978-3-319-22822-8_15 \(2015\)."),[11](https://www.nature.com/articles/s41590-026-02674-5#ref-CR11 "Houen, G. & Trier, N. H. Epstein–Barr virus and systemic autoimmune diseases. Front. Immunol. 11, 587380 https://doi.org/10.3389/fimmu.2020.587380 \(2021\)."),[12](https://www.nature.com/articles/s41590-026-02674-5#ref-CR12 "Iwata, S. & Tanaka, Y. Association of viral infection with the development and pathogenesis of systemic lupus erythematosus. Front. Med. 9, 849120 https://doi.org/10.3389/fmed.2022.849120 \(2022\)."),[13](https://www.nature.com/articles/s41590-026-02674-5#ref-CR13 "Álvarez-Lafuente, R. et al. Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction. Ann. Rheum.Dis. 64, 1357 https://doi.org/10.1136/ard.2004.033514 \(2005\)."),[14](https://www.nature.com/articles/s41590-026-02674-5#ref-CR14 "Bo, M. et al. Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens. Sci. Rep. 8, 1789 https://doi.org/10.1038/s41598-018-19957-z \(2018\)."),[15](https://www.nature.com/articles/s41590-026-02674-5#ref-CR15 "Hussein, H. M. & Rahal, E. A. The role of viral infections in the development of autoimmune diseases. Crit. Rev. Microbiol. 45, 394–412 https://doi.org/10.1080/1040841X.2019.1614904 \(2019\)."). The _Herpesviridae_ family consists of three subfamilies based on similarities in virus size and structure: _Alphaherpesvirinae_ contains _Simplexvirus_ and _Varicellovirus_ genera, _Betaherpesvirinae_ contains _Cytomegalovirus_ and _Roseolovirus_ genera, and _Gammaherpesvirinae_ contains _Lymphocryptovirus_ and _Rhadinovirus_ genera[16](https://www.nature.com/articles/s41590-026-02674-5#ref-CR16 "Davison, A. in Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis \(eds Arvin, A. et al.\) Ch. 1 \(Cambridge University Press, 2007\)."). Herpesviruses establish lifelong latency, manipulating host immune regulation and sustaining chronic immune activation, features that uniquely position them as candidate triggers of autoimmunity[2](https://www.nature.com/articles/s41590-026-02674-5#ref-CR2 "Cho, J. H. & Gregersen, P. K. Genomics and the multifactorial nature of human autoimmune disease. N. Engl. J. Med. 365, 1612–1623 https://doi.org/10.1056/NEJMra1100030 \(2011\)."),[17](https://www.nature.com/articles/s41590-026-02674-5#ref-CR17 "Sogkas, G. et al. Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell Mol. Immunol. 18, 1122–1140 https://doi.org/10.1038/s41423-020-00626-z \(2021\)."). For example, herpes simplex virus (HSV) 1 and 2 have been associated with develop
## Related Clinical Research

- [Molecular mimicry and autoimmune disease: review unavailable — summary of source limitations](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-molecular-mimicry-revisited-novel-perspectives-on-autoimmune-disease-initiation.md)
- [B-cell centrality and therapeutic response in autoimmune diseases: systematic review overview](https://medichelpline.com/clinical-feed/frontiers-in-immunology-10-b-cell-centrality-dictates-therapeutic-efficacy-across-autoimmune-diseases-a.md)
- [Why a 13‑Year Diagnostic Delay in MS Resonates with Christina Applegate’s Case](https://medichelpline.com/clinical-feed/stat-news-1-opinion-it-took-me-13-years-to-be-diagnosed-with-ms-christina-applegate-s.md)
- [Emergency diagnosis frequency and outcomes across 13 non-cancer conditions in England: analysis of](https://medichelpline.com/clinical-feed/plos-medicine-2-frequency-and-prognostic-outcomes-of-emergency-diagnosis-in-13-non-neoplastic.md)
- [CAR-T cell therapy in autoimmune diseases: progress, challenges, and emerging technologies](https://medichelpline.com/clinical-feed/plos-medicine-0-progress-and-promise-of-car-t-cell-treatment-in-autoimmune-diseases.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.